KANGSTEM BIOTECH CO., LTD. financial statements, including revenue, expenses, profit, and loss

The total revenue of 217730 for the last quarter is 2.28 B KRW, and it's 21.96% lower compared to the previous quarter. The net income of Q2 24 is 4.71 B KRW.